Measuring Multivalent Interactions: Uncovering the Secrets of Virus Binding Strategies

The COVID-19 pandemic has brought virology to the forefront of many research programs. But how do we get ahead of the next viral threat? Limited commercial labs are licensed to conduct research using BSL-3 or BSL-4 pathogens.

For common groundwater contaminants such as chlorinated ethenes, demonstrating biodegradation activity based on detection of daughter products is straightforward, since the products are readily discernible from background sources. However, this is not the case for all contaminants. With chlorinated methane’s (i.e., carbon tetrachloride, chloroform, and dichloromethane), for example, anaerobic reductive dichlorination is not the only degradation pathway.

After watching this webinar, participants will be familiar with: basic settings and parameters of pacemakers; how to integrate and program pacemakers; and how to identify common pacemaker-related issues.

Toxicity failures caused by off-target or unintended on-target liabilities are a leading cause of attrition in clinical and preclinical programs. Given the effort, cost, and technical limitations of traditional biopharmaceutical de-risking strategies, there is a need for a robust and scalable approach that can be rapidly applied to the discovery phases of therapeutic programs. Join us for this exciting new GEN Webinar, where our panel of experts will discuss new approaches to de-risking lead selection of antibodies and other biotherapeutics.